Insider Confidence Grows as CFO Increases Stake in CervoMed William Elder, CervoMed’s CFO, acquired 4,233 more shares, raising his total holdings to 5,500 shares. This purchase, amid a trend of insider buying and no recent insider selling, signals leadership’s confidence in the biotech firm’s prospects as it advances treatments for neurological diseases, including dementia with Lewy bodies.34